Following strong results for its flagship CTX001 drug, should you add CRISPR to your portfolio?
Is CRISPR Therapeutics the Best Gene-Editing Stock Right Now?
Posted in biotech/medical, genetics
Posted in biotech/medical, genetics
Following strong results for its flagship CTX001 drug, should you add CRISPR to your portfolio?